drugset / Trial / NCT06462781

Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1

NCT06462781

NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to test whether injecting lidocaine and steroids into two blood vessels of the brain can help treat chronic headaches (migraines). The main questions this study aims to answer: is this treatment safe for chronic migraine patients? Participants will: * Be treated once with lidocaine and steroid infused into the middle meningeal arteries (two blood vessels in the brain). * Attend appointments scheduled 1 week, 6 weeks, and 12 weeks after the treatment for a checkup. * Keep a log of their symptoms.

Timeline

Start
2024-03-15
Primary completion
2025-05-13
Completion
2025-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 80 mg Other
Subject Methylprednisolone Other / unclassified 40 mg Other

Indications